how common is stomach paralysis with semaglutide Lawsuit Filed Against Ozempic, Mounjaro Over 'Stomach Paralysis' Ozempic Gastroparesis Lawsuits | GLP-1

Over the next 48 weeks, those who stayed on semaglutide lost a further 7.9%, whereas those switched to placebo regained 6.9%

& Bendtson, I

By blocking TREK-1, PE-22-28: Increases neuronal excitability : Reduces potassium efflux, depolarizing neurons toward firing threshold Enhances serotonergic transmission : TREK-1 is expressed on serotonergic neurons in the dorsal raphe nucleus

stop if dizzy, nauseous, or unusually breathless

Reviews in Endocrine and Metabolic Disorders , 15 (3), 181-187

Summary: Ozempic may lead to modest improvements in cholesterol levels as a secondary effect, primarily through weight loss, but it is not licensed or recommended as a cholesterol-lowering medication in the UK